Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence (SIZE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT00775879
First received: October 17, 2008
Last updated: May 17, 2013
Last verified: May 2013

October 17, 2008
May 17, 2013
March 2006
July 2008   (final data collection date for primary outcome measure)
Incidence of spike wave [ Time Frame: during anaesthesia induction with sevoflurane ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00775879 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence
Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence

Sevoflurane is widely used for induction of anaesthesia. Several studies showed EEG abnormalities during mask induction with sevoflurane. The aim of our study was to test the induction target concentration of sevoflurane on the spikes wave occurrence.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
General Anesthesia
Drug: Induction with Sevoflurane
  • Experimental: A
    2.5% target concentration
    Intervention: Drug: Induction with Sevoflurane
  • Active Comparator: B
    2.5% manually selected
    Intervention: Drug: Induction with Sevoflurane
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
34
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • programmed gynecological surgery
  • ASA 1 or 2

Exclusion Criteria:

  • arterial hypertension
  • gastro-oesophageal reflux
  • pregnancy
  • diabetes
  • obesity
  • asthma
  • tobacco
Female
18 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00775879
CHUBX 2004/01
No
University Hospital, Bordeaux
University Hospital, Bordeaux
Not Provided
Principal Investigator: Benjamin JULLIAC, Dr University Hospital, Bordeaux
University Hospital, Bordeaux
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP